Mouse Anti-ITGB5 Recombinant Antibody (1D8) (CBMAB-A4588-LY)

Gu, L., Jin, X., Liang, H., Yang, C., & Zhang, Y. (2023). Upregulation of CSNK1A1 induced by ITGB5 confers to hepatocellular carcinoma resistance to sorafenib in vivo by disrupting the EPS15/EGFR complex. Pharmacological Research, 192, 106789.

Liu, D., Liu, S., Fang, Y., Liu, L., & Hu, K. (2022). Comprehensive analysis of the expression and prognosis for ITGBs: identification of ITGB5 as a biomarker of poor prognosis and correlated with immune infiltrates in gastric cancer. Frontiers in Cell and Developmental Biology, 9, 816230.

Wen, X., Chen, S., Chen, X., Qiu, H., Wang, W., Zhang, N., ... & Zhang, L. (2022). ITGB5 promotes innate radiation resistance in pancreatic adenocarcinoma by promoting DNA damage repair and the MEK/ERK signaling pathway. Frontiers in Oncology, 12, 887068.

Yang, Y., Feng, Q., Hu, K., & Cheng, F. (2021). Using CRISPRa and CRISPRi technologies to study the biological functions of ITGB5, TIMP1, and TMEM176B in prostate cancer cells. Frontiers in Molecular Biosciences, 8, 676021.

Wang, W., Liu, Y., Tang, H., Yu, Y., & Zhang, Q. (2019). ITGB5 plays a key role in Escherichia coli F4ac-induced diarrhea in piglets. Frontiers in Immunology, 10, 2834.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols